Clementia Pharmaceuticals, Inc.
(NASDAQ : CMTA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 2.84%132.470.7%$2115.80m
PFEPfizer Inc. 2.99%32.700.9%$1405.89m
MRKMerck & Co., Inc. 3.94%76.710.7%$1313.96m
ABBVAbbVie, Inc. 2.00%74.892.3%$1247.77m
BMYBristol-Myers Squibb Co. 1.23%55.041.0%$1087.59m
LLYEli Lilly & Co. 3.69%141.461.1%$922.03m
NVSNovartis AG 2.88%83.260.2%$311.04m
AZNAstraZeneca Plc -0.57%43.531.2%$286.09m
GSKGlaxoSmithKline Plc 1.21%37.670.2%$263.94m
FTSVForty Seven, Inc. -0.01%95.430.0%$220.27m
NVONovo Nordisk A/S -1.40%58.920.1%$173.75m
SNYSanofi 0.86%43.280.2%$157.86m
BHCBausch Health Cos., Inc. -1.60%13.530.0%$91.26m
RARXRa Pharmaceuticals, Inc. -0.03%48.000.8%$83.59m
RGENRepligen Corp. 1.54%95.787.1%$73.17m

Company Profile

Clementia is a biopharmaceutical company dedicated to bringing effective new treatments to people who have none. Clementia is rapidly developing its first lead product candidate, palovarotene, to treat fibrodysplasia ossificans progressiva (FOP), an ultra-rare and severely disabling disorder, and other diseases.